Receptor Tyrosine Kinase (RTK) mediated tyrosine phosphor-proteome from Drosophila S2 (ErbB1) cells reveals novel signaling networks

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Krishnamoorthy, Srinivasan ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DROSOPHILA PROTEIN; EPIDERMAL GROWTH FACTOR; INSULIN; PROTEIN TYROSINE KINASE; PROTEOME; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHOPEPTIDE; PHOSPHOPROTEIN;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DROSOPHILA; ENZYME ACTIVATION; GENETIC CONSERVATION; HIGH THROUGHPUT SCREENING; HUMAN; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PARALOGY; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; VALIDATION PROCESS; ANIMAL; DEGENERATIVE DISEASE; ENZYMOLOGY; GENETICS; METABOLISM; NEOPLASM; PHYSIOLOGY; SPECIES DIFFERENCE;

ANIMALS; CONSERVED SEQUENCE; DROSOPHILA; DROSOPHILA PROTEINS; EPIDERMAL GROWTH FACTOR; HUMANS; INSULIN; NEOPLASMS; NEURODEGENERATIVE DISEASES; PHOSPHOPEPTIDES; PHOSPHOPROTEINS; PROTEIN-TYROSINE KINASES; PROTEOME; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY;

EID: 51449083336     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002877     Document Type: Article

References (19)

1. Fishman MC, Porter JA (2005) Pharmaceuticals: a new grammar for drug discovery. Nature 437(7058): 491-493.
2. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar G, et al. (2006) Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks. Cell 127: 635-648.
3. Marmor MD, Skaria KB, Yarden Y (2004) Signal transduction and oncogenesis by ErbB/HER receptors. Int J Radiat Oncol Biol Phys 58(3): 903-913.
4. McMahon G (2000) VEGF receptor signaling in tumor angiogenesis. Oncologist 5 Suppl 1: 3-10.
5. Sharma SV, Bell DW, Settleman J, Haber DA (2007) Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7(3): 169-181.
6. Nam NH, Parang K (2003) Current targets for anticancer drug discovery. Curr Drug Targets 4(2): 159-179.
7. Schiller JH (2008) Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000). Cancer Invest 26: 81-95.
8. Haluska F, Pemberton T, Ibrahim N, Kalinsky K (2007) The RTK/RAS/BRAF/ PI3K pathways in melanoma: biology, small molecule inhibiton, and potential applications. Semin Oncol 34(6): 546-554.
9. Rush J, Moritz A, Lee KA, Guo A, Goss VL, et al. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nature Biotechnol 23(1): 94-101.
10. Schumacher JA, Crockett DK, Elenitoba-Johnson KSJ, Lim MS (2007) Evaluation of enrichment techniques for mass spectroscopy. Identification of tyrosine phosphorylation cancer cells. J Mol Diagn 9(2): 169-77.
11. Bodenmiller B, Malmstrom J, Gerrits B, Campbell D, Lam H, et al. (2007) PhosphoPep - a phosphoproteome resource for systems biology research in Drosophila Kc167 cells. Mol Syst Biol 3: 139.
12. Friedman A, Perrimon N (2006) A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signaling. Nature 444(7116): 230-234.
13. Guo A, Villén J, Kornhauser J, Lee KA, Stokes MP, et al. (2008) Signaling networks assembled by oncogenic EGFR and c-Met. Proc Natl Acad Sci U S A 105(2): 692-697.
14. Chang YC, Lin SY, Liang SY, Pan KT, Chou CC, et al. (2008) Tyrosine Phosphoproteomics and Identification of Substrates of Protein Tyrosine Phosphatase dPTP61F in Drosophila S2 Cells by Mass Spectrometry-Based Substrate Trapping Strategy. J. Proteome Res. 7(3): 1055-1066.
15. Altenberg B, Greulich KO (2001) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84(6): 1014-20.
16. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, et al. (2008) The M2 splice isororm of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452(7184): 230-3.
17. Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI (2006) Increased brain monocarboxylic acid transport and utilization in type 1 diabetes. Diabetes 55(4): 929-934.
18. Paweletz CP, Charboneau L, Bichsel VE, Simone NE, Chen T, et al. (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20: 1981-1989.
19. Jones RB, Gordus A, Krall JA, MacBeath G (2006) A quantitative protein interaction network for the ErbB recepters using protein microarrays. Nature 439: 168-174.